PHOTO: Cancer Patient Who Contracted Disease After Using Johnson & Johnson Talcum Powder Wins $70million Payout From The Company

Deborah Giannecchini, pictured, of Modesto, California claimed using Johnson & Johnson's baby powder in an intimate fashion over many years led to her developing ovarian cancer
A jury has awarded a woman $70million in damages against Johnson & Johnson after the woman claimed talcum powder caused her ovarian cancer. Deborah Giannecchini of Modesto, California was diagnosed with the disease in 2012 and accused the company of 'negligent conduct' in making and and marketing the baby powder. 

The lawsuit claimed Mrs Giannecchini contracted the disease after using baby powder in an intimate area. 

Jim Onder, Mrs Giannecchini's lawyer, said: 'We are pleased the jury did the right thing. They once again reaffirmed the need for Johnson & Johnson to warn the public of the ovarian cancer risk associated with its product.' 

However, the company has rejected there is any risk to using their product - even in intimate areas - and will appeal the massive award. Carol Goodrich, spokesman for the company said: 'We deeply sympathize with the women and families impacted by ovarian cancer. We will appeal today's verdict because we are guided by the science, which supports the safety of Johnson's Baby Powder.'

Deborah Giannecchini of Modesto, California claimed using Johnson & Johnson's baby powder in an intimate fashion over the course of many years led to her developing ovarian cancer 
Much research has found no link or a weak one between ovarian cancer and using baby powder for feminine hygiene, and most major health groups have declared talc harmless. Johnson & Johnson, whose baby powder dominates the market, maintains it's perfectly safe.

But Onder of the Onder Law Firm in suburban St Louis, which represented plaintiffs in all three St Louis cases, cited other research that began connecting talcum powder to ovarian cancer in the 1970s. He said case studies have indicated that women who regularly use talc on their genital area face up to a 40 per cent higher risk of developing ovarian cancer.

Onder has accused Johnson & Johnson of marketing toward overweight women, blacks and Hispanics - the very same women most at risk for ovarian cancer, he said. Factors known to increase a women's risk of ovarian cancer include age, obesity, use of estrogen therapy after menopause, not having any children, certain genetic mutations and personal or family history of breast or ovarian cancer.


Credit: Daily Mail

Share on Google Plus

0 comments:

Post a Comment

Thanks For Visiting My Blog...